IQVIA Holdings, Inc. (IQV) Financials
IQV Assets vs Liabilities
Date | Assets | Liabilities |
---|---|---|
2023-12-31 | 26.7 billion | 20.6 billion |
2023-09-30 | 26.0 billion | 20.2 billion |
2023-06-30 | 26.0 billion | 20.3 billion |
2023-03-31 | 25.7 billion | 19.8 billion |
IQV Free Cash Flow and Stock based compensation
Graph available only for supporters. Become a supporter to see it.
Date | Free Cash Flow | Stock based compensation |
---|---|---|
2023-12-31 | 568.0 million | 45.0 million |
2023-09-30 | 437.0 million | 47.0 million |
2023-06-30 | 242.0 million | 50.0 million |
2023-03-31 | 253.0 million | 75.0 million |
IQV Net Income
Graph available only for supporters. Become a supporter to see it.
Date | Net Income |
---|---|
2023-12-31 | 469.0 million |
2023-09-30 | 303.0 million |
2023-06-30 | 297.0 million |
2023-03-31 | 289.0 million |
IQV Cash and Debt
Graph available only for supporters. Become a supporter to see it.
Date | Cash | Debt | Capital Lease |
---|---|---|---|
2023-12-31 | 1.5 billion | - | 223.0 million |
2023-09-30 | 1.3 billion | 12.3 billion | 217.0 million |
2023-06-30 | 1.5 billion | 12.4 billion | 242.0 million |
2023-03-31 | 1.6 billion | 11.8 billion | 255.0 million |
IQV Shares Outstanding
IQV Expenses
Graph available only for supporters. Become a supporter to see it.
Date | Capex | R&D | G&A | S&M |
---|---|---|---|---|
2023-12-31 | 179.0 million | - | 556.0 million | - |
2023-09-30 | 146.0 million | - | 502.0 million | - |
2023-06-30 | 160.0 million | - | 482.0 million | - |
2023-03-31 | 164.0 million | - | 513.0 million | - |
IQV Cost of Revenue
Graph available only for supporters. Become a supporter to see it.
Date | Revenue | Cost of Revenue |
---|---|---|
2023-12-31 | 3.9 billion | 2.8 billion |
2023-09-30 | 3.7 billion | 2.4 billion |
2023-06-30 | 3.7 billion | 2.4 billion |
2023-03-31 | 3.7 billion | 2.4 billion |
IQV
Price: $234.88
52 week price:
Earnings Per Share: 7.28 USD
P/E Ratio: 40.78
Exchange: NYQ
Sector: Healthcare
Industry: Diagnostics & Research
Volume: 286158
Market Capitalization: 42.5 billion